November 12, 2025 Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia Shawn Griffin and others
August 21, 2025 Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma Shawn Griffin and others
June 23, 2025 R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma Shawn Griffin, Alexandre Chan
May 21, 2025 Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer Christine Cadiz, Shawn Griffin and others
April 22, 2025 Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT) Shawn Griffin and others
January 8, 2025 Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation Shawn Griffin and others
November 5, 2024 Final Results of a Prospective Obervational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation Shawn Griffin and others
November 5, 2024 Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation Shawn Griffin and others
November 5, 2024 Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherarpy without Increased Toxicity in Newly Diagonised Acute Myeloid Leukemia Shawn Griffin and others
October 23, 2024 Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience Shawn Griffin and others
